Dr. Timothy Dale McClure, MD

Dr. McClure practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. McClure's NPI, 1992977342, was assigned on March 26, 2008. Dr. McClure graduated from University Of Washington School Of Medicine in 2004. Dr. McClure's California license number on file is A95976.

Dr. McClure's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. McClure's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. Dr. McClure is also affiliated with Hospital for Special Surgery. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. McClure to 2 more clinical labs and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McClure practices, 4 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. McClure's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. McClure is board certified in interventional radiology and diagnostic radiology by the American Board of Radiology. Dmand AI has Dr. McClure's licenses on file in 4 states: California, New York, Washington and Ohio.

Dmand AI lists enlarged prostate, kidney cysts, kidney stone disease, prostate cancer, urinary endoscopy, urine flow blockage and UTI among the conditions Dr. McClure treats.

CMS data shows 1,170 Medicare services from Dr. McClure across 19 procedure codes in 2024, for 523 Medicare patients. Medicare paid $127,806 for them.

CMS counts 523 Medicare patients who saw Dr. McClure in 2024. The largest group is 65 to 74, with 237 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McClure's median patient age at 74, with 8% women.

In 2024, Dr. McClure wrote 16 Medicare Part D claims. 100% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. McClure for performance year 2024, reported through an alternative payment model (APM). Dr. McClure accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McClure as offering telehealth.

Dmand AI links 43 papers to Dr. McClure, published from 2005 to 2024. 2024 was the busiest year, with 10. The most frequent topics are Prostatic Neoplasms, Prostate and Embolization, Therapeutic. Dr. McClure has published most often in J Vasc Interv Radiol. Dr. McClure's most frequent co-authors are Jim C. Hu, MD, MPH, Christopher E. Barbieri, MD, PhD and Daniel Margolis, MD.

CMS Open Payments shows 51 general payments to Dr. McClure from 12 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 81% of the total. Telix Pharmaceuticals paid the most, $16,191.

Dr. McClure graduated from University Of Washington School Of Medicine in 2004.

Dr. McClure is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.